CL

Curt LaBelle

Dr LaBelle has been actively involved in the healthcare industry for over 20 years, both operationally and as an investor. Dr LaBelle is President at the Global Health Investment Fund (GHIF), a social impact investment fund, which manages US$108m backed by the Gates Foundation, JP Morgan and others. He also serves as a director on the boards of Z Optics, Revelation Bio and Atticus Medical. Prior to joining GHIF, Dr LaBelle was Managing Director at Tullis Health Investors and Vice President at Investor Growth Capital.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AT1
AT1
19/12/23240,00064,811,2800N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AT1
AT1
11/04/23
Expiry
1,200,000$0.040$48,000Options expired
AT1
AT1
06/04/22
Expiry
1,200,000$0.120$144,000Options expired
AT1
AT1
09/04/21
Buy
240,000$0.156$37,500Exercise of options
AT1
AT1
09/04/21
Exercise
960,000$0.156$150,000Exercise of options
AT1
AT1
09/04/21
Buy
960,000$0.156$150,000Exercise of options